- Home
- NERV vs ENFY Comparison
NERV vs ENFY Comparison
Compare NERV & ENFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- ENFY
- Stock Information
- Founded
- NERV 2007
- ENFY 1987
- Country
- NERV United States
- ENFY China
- Employees
- NERV N/A
- ENFY 424
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- ENFY
- Sector
- NERV Health Care
- ENFY
- Exchange
- NERV Nasdaq
- ENFY NYSE
- Market Cap
- NERV 16.0M
- ENFY 11.8M
- IPO Year
- NERV 2014
- ENFY N/A
- Fundamental
- Price
- NERV $2.23
- ENFY $0.80
- Analyst Decision
- NERV Hold
- ENFY
- Analyst Count
- NERV 1
- ENFY 0
- Target Price
- NERV $5.00
- ENFY N/A
- AVG Volume (30 Days)
- NERV 37.0K
- ENFY 50.0K
- Earning Date
- NERV 02-20-2025
- ENFY 02-07-2025
- Dividend Yield
- NERV N/A
- ENFY N/A
- EPS Growth
- NERV N/A
- ENFY N/A
- EPS
- NERV N/A
- ENFY N/A
- Revenue
- NERV N/A
- ENFY $90,812,865.00
- Revenue This Year
- NERV N/A
- ENFY N/A
- Revenue Next Year
- NERV N/A
- ENFY N/A
- P/E Ratio
- NERV N/A
- ENFY N/A
- Revenue Growth
- NERV N/A
- ENFY N/A
- 52 Week Low
- NERV $2.06
- ENFY $0.75
- 52 Week High
- NERV $13.49
- ENFY $3.32
- Technical
- Relative Strength Index (RSI)
- NERV 50.40
- ENFY N/A
- Support Level
- NERV $2.07
- ENFY N/A
- Resistance Level
- NERV $2.39
- ENFY N/A
- Average True Range (ATR)
- NERV 0.12
- ENFY 0.00
- MACD
- NERV -0.01
- ENFY 0.00
- Stochastic Oscillator
- NERV 48.48
- ENFY 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About ENFY ENLIGHTIFY INC
Enlightify Inc Formerly China Green Agriculture Inc is engaged in the business of fertilizer and agricultural products. It involves the research, development, production, distribution, and sale of humic acid-based compound fertilizers, blended fertilizers, organic compound fertilizers, slow-release fertilizers, concentrated water-soluble fertilizers, and mixed organic-inorganic compound fertilizers and the development, production, and distribution of agricultural products, such as top-grade fruits, vegetables, flowers and colored seedlings in China. The company operates in four segments: Jinong (fertilizer production), Gufeng (fertilizer production), Yuxing (agricultural products production), and Antaeus (Bitcoin). All of its operations are conducted in China.